Macrolides a risk in early pregnancy

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

Avoid prescribing macrolides to pregnant women, say UK researchers after they found the antibiotics were associated with an increased risk of significant birth defects, particularly cardiac defects.

The study is certainly going to cause some concern as to date macrolides such as erythromycin, clarithromycin and azithromycin are commonly prescribed here in Australia especially to patients who are allergic to penicillin. And given their category A pregnancy safety rating in this country, many GPs would not have thought twice about writing a script for any of these antibiotics for women who were, or potentially were, pregnant.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

Fan H, Gilbert R, O’Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ. 2020; 368: m331. DOI: 10.1136/bmj.m331

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

Do you agree or disagree that, in general, the majority of care plans are achieving their intended goal for the patient?

Strongly agree

0%

Slightly agree

0%

Slightly disagree

0%

Strongly disagree

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.